President Trump Is Expanding Access to Fertility Care Through TrumpRX
By The Conservateur Team
President Donald Trump makes an announcement on prescription drug prices in the Roosevelt Room, Friday, December 19, 2025. (Official White House Photo by Joyce N. Boghosian)
For millions of American women, the journey to motherhood is shaped not just by biology but by cost. Fertility treatments often require expensive prescription medications that are rarely covered by insurance, forcing families to make painful financial decisions at the very moment they are trying to build a future. Under Donald J. Trump, that reality is beginning to change.
President Trump pledged to confront rising prescription drug prices and his administration is now delivering meaningful relief to women struggling with infertility. With TrumpRx.gov officially live, Americans can directly purchase prescription drugs at discounted prices, including fertility medications that are typically paid for out of pocket. This new approach is expanding access and putting families first.
As White House spokesperson Kush Desai explained, “President Trump pledged to reduce drug prices for American patients. With TrumpRx.gov officially live, Americans can now directly purchase prescription drugs including fertility drugs that are not usually covered by insurance. The President continues to prove the so called experts wrong and this is just the beginning, as TrumpRx.gov will continually be updated to include more drugs at discounted prices for Americans.”
For women navigating infertility, these changes are deeply personal. Many patients pay thousands of dollars per cycle for fertility medications alone. Under this new initiative, patients struggling with infertility will save more than two thousand dollars per cycle on average, dramatically reducing one of the biggest barriers to treatment and family building.
The savings on individual medications are significant. Gonal F, one of the most commonly used fertility drugs in the country, will now be available for as low as one hundred sixty eight dollars per pen depending on dosage strength. Cetrotide, another widely used fertility medication, will see its price drop from three hundred sixteen dollars to just twenty two dollars and fifty cents. The price of Ovidrel will fall from two hundred fifty one dollars to eighty four dollars. These reductions translate into real access and real opportunity for women who have long been priced out of care.
These efforts reflect why this White House is widely regarded as the most pro family and pro woman administration in recent history. Rather than relying on rhetoric, President Trump has prioritized practical policies that lower costs and empower women to make decisions about their health and their families. Addressing the often overlooked cost of fertility care is a powerful affirmation that women and families matter.
With TrumpRx.gov now live and expanding, this administration is sending a clear message: building a family should not depend on financial privilege. For women hoping to become mothers, these reforms offer renewed hope, expanded access, and a future that feels more within reach.
